Since November 1, Peggy Lillis Foundation’s second annual “See C. diff” campaign has exploded on social media. As of November 18, we have reached more than double the number of people we did in the entire month of November 2019 (180,000 versus 80,000). In terms of impressions (the number of …
Peggy Lillis Foundation’s annual Summit has often created the opportunity for C. diff advocates to connect with clinicians, researchers, and industry representatives. We feared that taking it virtual would hinder those connections. Turns out we needn’t have worried. Among the connections made at this year’s Summit was one between Idaho-based …
April 2020 marked a decade since we lost Peggy Lillis to a community-acquired C. difficile infection and founded the Peggy Lillis Foundation (PLF) to combat this disease. It also marked our fifth National C. diff Advocacy Summit. Initially planned to once again be held in Washington, DC, due to COVID-19 PLF …
Fecal microbiota transplant (FMT) as a treatment for C. difficile infections has skyrocketed over the past decade. While it has saved tens of thousands of lives, FMT remains controversial and the Food and Drug Administration (FDA) has been slow to formalize its regulatory status. This has left doctors, scientists, drug …
The Food and Drug Administration (FDA) issued a Safety Alert today Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to COVID-19. According to the alert, “FDA is informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal …
